Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Female
LinkedIn View on LinkedIn
Barbara Yanni has served as a member of Vaccinex's board of directors since February 2015. Ms. Yanni was Vice President and Chief Licensing Officer at Merck & Co., Inc., a publicly traded pharmaceutical company, from November 2001 until her retirement in March 2014. Prior to this, Ms. Yanni served in various roles at Merck including in
corporate development, financial evaluation and tax. She currently serves on the boards of Trevena, Inc., a publicly traded biopharmaceutical company, and also serves on the board of a privately held biopharmaceutical company, Symic Bio, Inc. Ms. Yanni received an A.B. from Wellesley College, a J.D. from Stanford Law School and an LL.M. from New York University. Ms. Yanni’s experience in biotechnology and pharmaceutical business evaluation and transaction execution, her financial and general business knowledge, and her service as a director of other publicly traded and privately held life science companies give her the qualifications, skills and financial expertise to serve on Vaccinex's board of directors.
